8 results for author:"Zarranz J.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (10)
| Initial neuropsychological impairments in patients with the E46K mutation of the alpha-synuclein gene (PARK 1). Somme J.H., Gomez-Esteban J.C., Molano A., Tijero B., Lezcano E., Zarranz J.J. J. Neurol. Sci. 310:86-89(2011) · Mapped (7) |
| Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Mata I.F., Hutter C.M., Gonzalez-Fernandez M.C., de Pancorbo M.M., Lezcano E., Huerta C., Blazquez M., Ribacoba R., Guisasola L.M., Salvador C. et al. Neurogenetics 10:347-353(2009) · Mapped (4) |
| LRRK2 mutations in Basque patients with Parkinson's disease. Zarranz J.J., Gomez-Esteban J.C. Lancet Neurol 7:866-7; author reply 2008:867-867(2008) · Mapped (4) |
| Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation. Rodriguez-Martinez A.B., Alfonso-Sanchez M.A., Pena J.A., Sanchez-Valle R., Zerr I., Capellari S., Calero M., Zarranz J.J., de Pancorbo M.M. Neurogenetics 9:109-118(2008) · Mapped (19) |
| Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain. Gonzalez-Fernandez M.C., Lezcano E., Ross O.A., Gomez-Esteban J.C., Gomez-Busto F., Velasco F., Alvarez-Alvarez M., Rodriguez-Martinez M.B., Ciordia R., Zarranz J.J. et al. Parkinsonism Relat. Disord. 13:509-515(2007) · Mapped (4) |
| A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Zarranz J.J., Ferrer I., Lezcano E., Forcadas M.I., Eizaguirre B., Atares B., Puig B., Gomez-Esteban J.C., Fernandez-Maiztegui C., Rouco I. et al. Neurology 64:1578-1585(2005) · UniProtKB (1) |
| The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B. et al. Ann. Neurol. 55:164-173(2004) · UniProtKB (1) |
| 5-Hydroxytryptamine 6 receptor (5-HT(6)) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country. Alvarez-Alvarez M., Galdos L., Fernandez-Martinez M., Gomez-Busto F., Garcia-Centeno V., Arias-Arias C., Sanchez-Salazar C., Rodriguez-Martinez A.B., Zarranz J.J., de Pancorbo M.M. Neurosci. Lett. 339:85-87(2003) · Mapped (7) |